Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Becton Dickinson/Abbott

This article was originally published in The Gray Sheet

Executive Summary

Immunological platelet analysis assay using BD's CD61 fluorescence-labeled monocolonal antibody and Abbott's Cell-Dyn 4000 hematology system will be the first product from the firms' new alliance aimed at developing novel fully automated immuno-hematology applications. The deal calls for combining Abbott's automated hematology systems with BD's flow cytometry, reagent technology and blood collection systems. Other applications in the pipeline include CD4 and CD8 count capability for the Cell-Dyn 4000



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts